F542-0802 Screening compound: 6-{5-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,2,4-oxadiazol-3-yl}-1-(2-methylpropyl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione

F542-0802 Screening compound: 6-{5-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,2,4-oxadiazol-3-yl}-1-(2-methylpropyl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione
F542-0802 Screening compound: 6-{5-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,2,4-oxadiazol-3-yl}-1-(2-methylpropyl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound F542-0802
6-{5-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,2,4-oxadiazol-3-yl}-1-(2-methylpropyl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F542-0802

Molecular Formula

C24H24N4O5 (C24 H24 N4 O5)

Compound Name

6-{5-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,2,4-oxadiazol-3-yl}-1-(2-methylpropyl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione

IUPAC name

6-{5-[(1E)-2-(34-dimethoxyphenyl)ethenyl]-124-oxadiazol-3-yl}-1-(2-methylpropyl)-1234-tetrahydroquinoxaline-23-dione

SMILES

CC(C)CN(c(ccc(-c1noc(/C=C/c(cc2)cc(OC)c2OC)n1)c1)c1NC1=O)C1=O

InChI

InChI=1S/C24H24N4O5/c1-14(2)13-28-18-8-7-16(12-17(18)25-23(29)24(28)30)22-26-21(33-27-22)10-6-15-5-9-19(31-3)20(11-15)32-4/h5-12,14H,13H2,1-4H3,(H,25,29)

InChI Key

QAMMGNUWTUONSQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27174964

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.48

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.899

Distribution Coefficient, logD

4.880

Water Solubility, LogSw

-4.58

Polar Surface Area

86.902

Acid Dissociation Constant (pKa)

8.75

Base Dissociation Constant (pKb)

-0.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

F542-0802 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F542-0802 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F542-0802?
Check Price and Availability of F542-0802, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F542-0802 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F542-0802
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F542-0802
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F542-0802 available by request